{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:38:58Z","timestamp":1783456738934,"version":"3.55.0"},"reference-count":19,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Southwest London Integrated Care Board"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2025,3,10]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Hospital admissions to treat fluid overload are common in patients with both heart failure and chronic kidney disease (CKD-HF). This is a population with high levels of frailty. Recurrent hospital admissions are costly to both patients and healthcare systems. We designed a proof-of-concept, multidisciplinary quality improvement project to deliver at-home subcutaneous furosemide to treat fluid overload in patients with CKD-HF. This project involved collaboration between a hospital, community remote monitoring hub and hospital-at-home team, including general practitioners, secondary care physicians, nurses and pharmacists. Patients were considered suitable for the intervention if they had CKD-HF, fluid overload and were haemodynamically stable. Following review, suitable patients were treated at-home with 80\u2009mg subcutaneous furosemide over 5\u2009hours, for 5\u2009days. This was administered by the hospital-at-home team in liaison with hospital specialists, with continuous patient monitoring provided by the remote monitoring hub. Renal function and weight were assessed daily. Following treatment, patients were reviewed by the secondary-care team to adjust their maintenance medications. Data collected and analysed included daily weights, renal function and observations, as well as the number of hospitalisations and\/or death at 30 days following the intervention. 10 patients successfully completed treatment. All potentially required hospitalisation at baseline and all avoided hospitalisation during the 5-day course of subcutaneous furosemide. One patient was admitted to the hospital following their final hospital review, and two patients were hospitalised for 4 and 14 days respectively, after their final dose of subcutaneous furosemide. Renal function and potassium did not significantly change throughout the treatment. No major safety concerns were identified. Patients welcomed the intervention. This quality improvement project demonstrates that it is logistically feasible, with primary care collaboration, to treat fluid overload in patients with CKD-HF at-home using subcutaneous furosemide.<\/jats:p>","DOI":"10.1136\/bmjoq-2024-002984","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T01:35:23Z","timestamp":1744335323000},"page":"e002984","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Domiciliary subcutaneous furosemide in patients with CKD and HF: a quality improvement project"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3462-7680","authenticated-orcid":false,"given":"Ella","family":"Tumelty","sequence":"first","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Montero","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Anenden","sequence":"additional","affiliation":[{"name":"Hospital At Home, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Nokes","sequence":"additional","affiliation":[{"name":"Central London Community Healthcare NHS Trust, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasa","family":"Gnanapragasam","sequence":"additional","affiliation":[{"name":"NHS England London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahrukh Ayesha","family":"Ali","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabba","family":"Hussain","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Chung","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Sunter","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bijman","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Williams","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M P","family":"Annear","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Chis Ster","sequence":"additional","affiliation":[{"name":"School of Health & Medical Sciences, St George\u2019s University of London, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rosano","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Anderson","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6863-2325","authenticated-orcid":false,"given":"Debasish","family":"Banerjee","sequence":"additional","affiliation":[{"name":"School of Health & Medical Sciences, St George\u2019s University of London, London, London, UK"},{"name":"Renal and Transplantation Unit, St George\u2019s University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"2025083114345055000_14.2.e002984.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht386"},{"key":"2025083114345055000_14.2.e002984.2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/ehf2.12185","article-title":"Impaired renal function affects clinical outcomes and management of patients with heart failure","volume":"4","author":"Jenkins","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2025083114345055000_14.2.e002984.3","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1002\/ehf2.12796","article-title":"Management and outcomes of heart failure patients with CKD: experience from an inter-disciplinary clinic","volume":"7","author":"Nguyen","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2025083114345055000_14.2.e002984.4","unstructured":"National heart failure audit (NHFA) 2023 summary report. 2023."},{"key":"2025083114345055000_14.2.e002984.5","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.ekir.2023.02.323","article-title":"WCN23-0449 the characteristics of hospital admissions in patients with chronic kidney disease and heart failure","volume":"8","author":"Parmar","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2025083114345055000_14.2.e002984.6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/ehf2.14693","article-title":"Investigating the relationship between FRailty And Quality of LIfe in patients with heart faiLure and CKD (FRAIL study)","volume":"11","author":"McNally","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2025083114345055000_14.2.e002984.7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/ejhf.2798","article-title":"Personalized care of patients with heart failure: are we ready for a REWOLUTION? Insights from two international surveys on healthcare professionals\u2019 needs and patients\u2019 perceptions","volume":"25","author":"Jankowska","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2025083114345055000_14.2.e002984.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c112","article-title":"The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies","volume":"340","author":"Morton","year":"2010","journal-title":"BMJ"},{"key":"2025083114345055000_14.2.e002984.9","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2016:25:2"},{"key":"2025083114345055000_14.2.e002984.10","unstructured":"All Party Parliamentary Group on Heart Disease . Focus on heart failure: 10 recommendations to improve care and transform lives. 2016."},{"key":"2025083114345055000_14.2.e002984.11","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2333"},{"key":"2025083114345055000_14.2.e002984.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2020-002803"},{"key":"2025083114345055000_14.2.e002984.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2017.10.001"},{"key":"2025083114345055000_14.2.e002984.14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ehjcvp\/pvad073","article-title":"A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies","volume":"10","author":"Osmanska","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025083114345055000_14.2.e002984.15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacbts.2017.10.001","article-title":"Subcutaneous Furosemide in Heart Failure","volume":"3","author":"Sica","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"2025083114345055000_14.2.e002984.16","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-020-00952-0"},{"key":"2025083114345055000_14.2.e002984.17","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s11886-024-02124-4","article-title":"The Role of Subcutaneous Furosemide in Heart Failure Management: A Systematic Review","volume":"26","author":"Widiarti","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"2025083114345055000_14.2.e002984.18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/fca-2023-0071","article-title":"Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study","volume":"19","author":"Bensimhon","year":"2023","journal-title":"Future Cardiol"},{"key":"2025083114345055000_14.2.e002984.19","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.913580","article-title":"Multimodal Strategies for the Diagnosis and Management of Refractory Congestion. An Integrated Cardiorenal Approach","volume":"13","author":"Rodr\u00edguez-Espinosa","year":"2022","journal-title":"Front Physiol"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2024-002984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T21:35:01Z","timestamp":1756676101000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2024-002984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4,10]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1136\/bmjoq-2024-002984"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2024-002984","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}